

Hexarelin 2mg
€12.00

Hexarelin 2mg
€12.00
- Description
- Benefits
- Risks
- Additional information
- Research
Description
Hexarelin is a synthetic hexapeptide belonging to the class of growth hormone releasing peptides (GHRPs). It is studied in laboratory environments for its role in growth hormone (GH) secretion, ghrelin receptor activation, and endocrine signalling pathways.
In controlled research settings, Hexarelin acts as a growth hormone secretagogue receptor (GHS-R) agonist, stimulating the release of growth hormone from the pituitary gland. It is often investigated for its potent GH-releasing activity compared to other peptides within the same class.
Across Ireland and Europe, Hexarelin is commonly used in research areas such as:
- Growth hormone secretion and regulation
- Ghrelin receptor (GHS-R) activation
- Endocrine and neuroendocrine pathway studies
- Hormonal signalling and metabolic research
This product is supplied as a high-purity research peptide, intended strictly for scientific and laboratory use.
Disclaimer: This product is strictly for research purposes only and is not for human consumption.
Technical Information – Hexarelin
| Specification | Details |
|---|---|
| Product Name | Hexarelin |
| Compound Type | Synthetic hexapeptide |
| Functional Class | Growth hormone releasing peptide (GHRP) |
| Mechanism of Action | Ghrelin receptor (GHS-R) agonist |
| Biological Targets | Pituitary gland, GHS-R receptors |
| Amino Acid Length | 6 amino acids |
| Format | Lyophilised powder |
| Purity | Research-grade (high purity) |
| Storage | Refrigerated (2–8°C, protected from light) |
| Application | Laboratory research use only |
* Images for illustration purposes only
Further Refrences: PubChem Entry
Researched Benefits & Focus Areas – Hexarelin
1. Growth Hormone (GH) Secretion Research
Hexarelin has been studied for:
- Strong stimulation of endogenous GH release
- Investigation of pituitary gland signalling pathways
- Analysis of hormonal secretion dynamics
Reference basis: Derived from endocrinology and pharmacology studies examining growth hormone releasing peptides and pituitary activation.
2. Ghrelin Receptor (GHS-R) Activation
Research has explored:
- Binding to growth hormone secretagogue receptors
- Influence on ghrelin signalling pathways
- Role in hormonal and metabolic regulation research
Reference basis: Based on biochemical studies investigating ghrelin receptor agonists and peptide-receptor interactions.
3. Cardiovascular & Cellular Signalling Research
Hexarelin has been investigated for:
- Interaction with cardiac and vascular signalling pathways (research models)
- Potential role in cellular protection mechanisms
- Influence on tissue signalling under stress conditions
Reference basis: Supported by preclinical research examining Hexarelin’s interaction with cardiovascular and cellular signalling systems.
4. Endocrine System Modulation
- Studied for its role in hormonal balance and signalling
- Explored in GH/IGF-1 axis research
- Investigated within neuroendocrine system models
Reference basis: Derived from clinical and experimental research into endocrine system regulation and peptide signalling.
Disclaimer: These are research-based findings only. This product is not intended for human use or consumption.
Researched Risks & Considerations – Hexarelin
1. Hormonal System Impact
- May significantly influence growth hormone levels
- Potential for endocrine imbalance in research models
Reference basis: Based on studies examining GH regulation and hormonal feedback systems.
2. Receptor Desensitisation
- Continuous stimulation may lead to reduced receptor responsiveness
- Potential for diminished effect over time in models
Reference basis: Derived from research into receptor desensitisation and peptide signalling dynamics.
3. Off-Target Biological Effects
- Possible interaction with non-target receptors
- Broad systemic influence across biological signalling pathways
Reference basis: Based on studies examining peptide distribution and multi-system interactions.
4. Limited Long-Term Research
- Lack of extensive long-term data
- Primarily studied in controlled laboratory environments
Reference basis: Reflects the current stage of growth hormone releasing peptide research.
Disclaimer: These risks are based on available research data only. This product is strictly a research peptide and not for human consumption.
Additional information
| Weight | 23 kg |
|---|---|
| Dimensions | 12 × 23 × 56 cm |
| Quantity | 1 Vial, 1 Kit (10 Vials) |